Group therapy via video for veterans with Mild Cognitive Impairment
Minds Navigating the Diagnosis of Mild Cognitive Impairment (MiND-MCI)
NA · Tuscaloosa Research & Education Advancement Corporation · NCT05690243
This study is testing whether a nine-week video group therapy program can help improve the well-being and quality of life for veterans with Mild Cognitive Impairment.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 160 (estimated) |
| Ages | 60 Years and up |
| Sex | All |
| Sponsor | Tuscaloosa Research & Education Advancement Corporation (other) |
| Drugs / interventions | chemotherapy, radiation |
| Locations | 2 sites (Tuscaloosa, Alabama and 1 other locations) |
| Trial ID | NCT05690243 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of a nine-week group therapy program delivered through video telehealth for veterans diagnosed with Mild Cognitive Impairment (MCI). Participants will engage in small group sessions and complete questionnaires to assess their well-being and quality of life before and after the intervention. The study will compare outcomes between veterans who start the therapy immediately and those who are placed on a waitlist. The trial will be conducted at two VA medical centers, involving a total of 160 veterans aged 60 and older.
Who should consider this trial
Good fit: Ideal candidates for this study are veterans aged 60 and older with a diagnosis of Mild Cognitive Impairment and at least one cardiovascular risk factor.
Not a fit: Patients with a diagnosis of dementia, serious mental illness, or other significant cognitive impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could enhance the well-being and quality of life for veterans suffering from Mild Cognitive Impairment.
How similar studies have performed: While the approach of using video telehealth for therapy is gaining traction, this specific intervention for veterans with MCI is relatively novel and has not been extensively tested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Veteran * age 60 or older * diagnosis of MCI, diagnosed at least a month or longer prior to screening * diagnosis of at least one cardiovascular risk factor (i.e., hypertension, diabetes mellitus II, hyperlipidemia/hypercholesterolemia, or obesity) * self-reported cognitive complaint (i.e., "Do you have problems with your memory or thinking abilities?") * self-reported difficulty adjusting to declines in cognitive functioning (i.e., "Have these problems with memory or thinking impacted you, your life, or others in your life?") * English speaking, and (h) ability to provide written informed consent Exclusion Criteria: * diagnosis of dementia or a neurodegenerative disorder * diagnosis of serious mental illness likely to impact cognition (i.e., schizophrenia or bipolar I disorder) * acutely suicidal or homicidal * actively psychotic * active substance use disorder * limited life expectancy due to a terminal medical condition * receiving ongoing chemotherapy or radiation treatment at time of screening * residing in an assisted living or residential care facility * currently participating in another psychotherapy, health promotion intervention, or cognitive training program, and * any significant changes to psychotropic medications or medications for memory and cognition in the past month. Participants prescribed psychotropic medications and medications for memory and cognition will be asked to stay on their current dosages for the duration of the study.
Where this trial is running
Tuscaloosa, Alabama and 1 other locations
- Tuscaloosa VA Medical Center — Tuscaloosa, Alabama, United States (RECRUITING)
- Salem VA Medical Center — Salem, Virginia, United States (RECRUITING)
Study contacts
- Principal investigator: Patricia Pilkinton, MD — Tuscaloosa Veterans Affairs Medical Center
- Study coordinator: Patricia Pilkinton, MD
- Email: patricia.pilkinton@va.gov
- Phone: 205-554-20944
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cognitive Dysfunction, Mild Cognitive Impairment, therapy, video telehealth, veteran